ArticleOncoTargets and therapy2025

Upregulation of SHIP2 Participates in the Development of Breast Cancer via Promoting Wnt/β-Catenin Signaling [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.